Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuvation Bio (NUVB)
NYSE:NUVB
Nuvation Bio (NUVB) Stock Price & Analysis
121 Followers
NUVB Stock Chart & Stats
Day’s Range$2.8 - $2.92
52-Week Range― - ―
Previous Close$2.88
Volume308.62K
Average Volume (3M)N/A
Market Cap
$623.19M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 13, 2024EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$6.40Price Target Upside124.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Nuvation Bio News
PremiumCompany Announcements
Nuvation Bio Expands and Refreshes Leadership with Acquisition
Ownership Overview
48.97% Insiders
20.61% Mutual Funds
7.03% Other Institutional Investors
23.39% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NUVB FAQ
What was Nuvation Bio’s price range in the past 12 months?
Currently, no data Available
What is Nuvation Bio’s market cap?
Currently, no data Available
When is Nuvation Bio’s upcoming earnings report date?
Nuvation Bio’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Nuvation Bio’s earnings last quarter?
Nuvation Bio released its earnings results on Feb 29, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.099 by $0.039.
Is Nuvation Bio overvalued?
According to Wall Street analysts Nuvation Bio’s price is currently Undervalued.
Does Nuvation Bio pay dividends?
Nuvation Bio does not currently pay dividends.
What is Nuvation Bio’s EPS estimate?
Nuvation Bio’s EPS estimate is -$0.09.
How many shares outstanding does Nuvation Bio have?
Currently, no data Available
What happened to Nuvation Bio’s price movement after its last earnings report?
Nuvation Bio reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.099. Following the earnings report the stock price went up 19.251%.
Which hedge fund is a major shareholder of Nuvation Bio?
Among the largest hedge funds holding Nuvation Bio’s share is Omega Fund Management, LLC. It holds Nuvation Bio’s shares valued at 23M.
---
Nuvation Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.40 (124.96% Upside)
$6.40 (124.96% Upside)
Blogger Sentiment
Bullish
NUVB Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 24.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 103.2%
Last 30 Days ▲ 103.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
60.00%
12-Months-Change
Fundamentals
Return on Equity
-12.03%
Trailing 12-Months
Asset Growth
-7.54%
Trailing 12-Months
Company Description
Nuvation Bio
Panacea Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
NUVB Stock 12 Months Forecast
Average Price Target
$6.40
▲(124.96% Upside)
Technical Analysis
Best Analysts Covering NUVB
1 Year
1 Year Success Rate
5/8 ratings generated profit
1 Year Average Return
+29.99%
reiterated a buy rating 2 months ago
Copying Gregory Renza's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +29.99% per trade.
---